Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 182 pseudogene (RNU7-182P) is a processed pseudogene related to the U7 small nuclear RNA (snRNA) gene family. U7 snRNA is an essential, functional small nuclear RNA required for processing histone pre-mRNAs in eukaryotic cells[3]. However, RNU7-182P itself is classified as a pseudogene, meaning it is a non-functional copy or derivative that does not produce a functional RNA or protein product[2][5][6]. There is no direct evidence that this pseudogene has a biological function, is involved in disease pathways, acts as a biomarker, or is a therapeutic target. Pseudogenes in general can occasionally exert regulatory functions or serve as competing endogenous RNAs, but no such roles are currently associated with RNU7-182P specifically[4]. Therefore, this entry is considered incorrect as a therapeutic or classical molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 182 pseudogene (RNU7-182P).